Our present study unveiled a novel role of the SRT1720-induced pharmacological activation of Sirt1 in protecting against the progression of obesity-related impaired angiogenesis and glucose intolerance. The gene discussed is SIRT1; the disease is obesity due to melanocortin 4 receptor deficiency.